Counselors in Sellersville, PA Accepting Medicare

171 Counselors found. Showing 81 - 100

Stephen Hrabyk, M.A. Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 807 Lawn Ave, Sellersville, PA 18960 Phone: 215-257-6551    Fax: 215-257-4453

Lesley Smith, M.ED. Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 807 Lawn Ave, Sellersville, PA 18960 Phone: 215-257-6551    Fax: 215-453-5181

Mrs. Pamela Lee Hermann, M.S. Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 807 Lawn Ave, Sellersville, PA 18960 Phone: 215-257-6551    Fax: 215-453-5181

Helen E Leatherman, M.S. Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 807 Lawn Ave, Sellersville, PA 18960 Phone: 215-257-6551    Fax: 215-257-6570

Jonathan T Barlow, M.S. Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 807 Lawn Ave, Sellersville, PA 18960 Phone: 215-257-6551    Fax: 215-453-5181

Karen M Williamson, M.S. Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 807 Lawn Ave, Sellersville, PA 18960 Phone: 215-257-6551    Fax: 215-453-5181

Heidi J Gordon, M.A., CADC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 807 Lawn Ave, Sellersville, PA 18960 Phone: 215-257-6551    Fax: 215-257-4008

Beth A Sheeran, M.A. Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 807 Lawn Ave, Sellersville, PA 18960 Phone: 215-257-6551    Fax: 215-257-9347

Meghan F Schrag, M.S.W. Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 807 Lawn Ave, Sellersville, PA 18960 Phone: 215-257-6551    Fax: 215-453-5181

Lynda L Goldschmidt, M.S. Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 807 Lawn Ave, Sellersville, PA 18960 Phone: 215-257-6551    Fax: 215-257-6570

Sara B St.onge, B.A. Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 807 Lawn Ave, Sellersville, PA 18960 Phone: 215-257-6551    Fax: 215-453-5181

Kimberly A Smith, M.S.W. Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 807 Lawn Avenue, Sellersville, PA 18960 Phone: 215-257-6551    Fax: 215-453-5181

Ronni L Sokolis, B.A. Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 807 Lawn Ave, Sellersville, PA 18960 Phone: 215-257-6551    Fax: 215-257-9347

Sheri B Herman, M.S. Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 807 Lawn Ave, Sellersville, PA 18960 Phone: 215-257-6551    Fax: 215-257-6570

Patrick J Kucas, B.S. Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 807 Lawn Ave, Sellersville, PA 18960 Phone: 215-257-6551    Fax: 215-453-5181

Dewayne James Brown, M.ED. Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 807 Lawn Ave, Sellersville, PA 18960 Phone: 215-257-6551    Fax: 215-257-6570

Mrs. Christiana J Mastrominas, LCSW Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 807 Lawn Ave, Sellersville, PA 18960 Phone: 215-257-6551    Fax: 215-257-4008

Mallorie Stafford, LPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 807 Lawn Ave, Sellersville, PA 18960 Phone: 215-257-6551    Fax: 215-257-9347

Korin Danchise-curtis, LPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 807 Lawn Ave, Sellersville, PA 18960 Phone: 215-257-6551    Fax: 215-257-9347

Adam J Skelding, M.ED. Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 807 Lawn Ave, Sellersville, PA 18960 Phone: 215-257-6551    Fax: 215-257-6570

News Archive

Emmaus Medical to complete target enrollment in L-Glutamine Phase III trial for sickle cell disease

In conjunction with Sickle Cell Awareness Month, Emmaus Medical, Inc., a specialty pharmaceutical and regenerative medicine technology company, announced that its U.S. Phase III clinical trial to study L-Glutamine as a treatment for sickle cell disease is nearing target enrollment completion, with investigation now underway at more than 30 clinical study sites throughout the U.S.

Antidepressant alert – Citalopram associated to heart rhythm disturbances

Antidepressant citalopram (Celexa, Forest Laboratories) should not be used in doses higher than 40 mg per day because of concerns that it can cause potentially fatal changes in heart rhythm, the US Food and Drug Administration (FDA) warns.

Muscle-sparing abdominal flaps can reduce complications in women undergoing breast reconstruction

In women undergoing breast reconstruction using their own (autologous) tissue, newer "muscle-sparing" abdominal flaps can reduce complications while improving some aspects of quality of life, reports a study in the March issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons.

FDA grants Abbott 510(k) clearance to market molecular diagnostic test for detection of chlamydia, gonorrhea

Abbott announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration to market a new, sensitive molecular diagnostic test and instrument to simultaneously detect two of the nation's most prevalent sexually transmitted diseases (STDs), gonorrhea and chlamydia, including a new variant strain of chlamydia recently discovered in Sweden.

UK lacks pathways through social and clinical care for eye patients

UK study results reveal that emotional and family support is lacking for individuals with visual impairment.

Read more Medical News

› Verified 1 days ago

• 1
• 2
• 3
• 4
• 5(current)
• 6
• 7
• 8
• 9